NASDAQ · Healthcare · Biotechnology
Ocular Therapeutix, Inc.
OCUL
Ocular Therapeutix, Inc. CEO Pravin U. Dugel · Market cap $2.0B.
$9.29
+0.13 · +1.39%
52w hi $16.4452w lo $6.23
Off 52w high 42.3%
60
NOTABLE
Current InsiderScore
Corp · 90d
2
1 buys · 1 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
1
0 strong · 1 notable
Analyst consensus
Strong Buy
Avg PT $25.50
Section 01
Recent Form 4 filings
3 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Feb 20 | Richard L Lindstrom MD | Buy | 60,229 | $7.66 | +$461K | 60 | |
| Feb 12 | Dugel Pravin | Executive Chairman, President and CEO | Sell | 124,882 | $9.04 | −$1.13M | 31 |
| May 08 | Richard L Lindstrom MD | Buy | 10,000 | $6.96 | +$70K | 36 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay